Top compounds associated with response to OR6C65


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 GDSC1000 pan-cancer AAC -0.065 0.05
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.065 0.05
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.066 0.05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.05
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.066 0.06
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.069 0.06
mRNA DMOG GDSC1000 pan-cancer AAC -0.062 0.06
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC -0.086 0.06
mRNA Zebularine CTRPv2 pan-cancer AAC -0.061 0.07
Download CSV